• Home
  • About
  • Blog
  • Insights
  • FAQ
Menu

Out-Thinking Parkinson's

Progressive Symptom Reduction Strategies for Parkinson's Disease
  • Home
  • About
  • Blog
  • Insights
  • FAQ

Dopamine Breakdown and Parkinson's Disease: Part 2

June 23, 2024

In Part 1, we looked at how the MAO enzyme breaks down Dopamine in the brain and body, via what we termed the “MAO pathway”. In this part, we consider another pathway by which Dopamine is broken down, via another enzyme called Catechol-O-methyltransferase (COMT).

We mentioned COMT already as being responsible for the last part of the MAO break down pathway, but it can also act directly on Dopamine itself. It not only breaks down Dopamine, but also Adrenaline (as does MAO too) [note, for shorthand, I will be using “Adrenaline” throughout to refer to both Noradrenaline and Adrenaline]. This has important ramifications since another way Dopamine may be used up is via conversion into Adrenaline under stressful conditions.

The Comt Pathway

COMT is an enzyme which degrades/inactivates not only Dopamine, but Noradrenaline and Adrenaline too. It also converts L-Dopa into something other than Dopamine, an issue we will return to do below.

In the Dopamine breakdown pathway, COMT first converts the Dopamine into something called 3-Methoxytyramine, before MAO comes back into the picture, to break this down further in to “MOPAL”. MOPAL is another aldyhyde, and recall that build up of Aldehydes are a problem for folks with PD. MOPAL is then broken down by the Aldehyde Dehydrogenase enzyme into the same final end point of the MAO pathway Homovanillic Acid (HVA), which is excreted in urine.

Slow and fast comt

There are rare genetic disorders in which the body creates too little or too much COMT, with significant impacts on Dopamine supplies. There are also different genetic types, including the so-called Slow and Fast COMT types. These two types remove/inactivate Dopamine and Adrenaline more slowly or more quickly, respectively.

Once again, disruption in the amount of COMT enzyme available or its activity may also occur due to being in chronic stress, and especially due to being stuck in the freeze stress response. Disruption due to chronic stress then mimics the features of these genetic types.

If chronic stress disrupts COMT in the direction of less COMT, or lower COMT activity, it will create features which mimic the Slow COMT type. These types are:

  • sensitive to stress, anxious, worriers;

  • sensitive to environment toxins;

  • sensitive to potentially traumatic events;

  • poor sleepers, daytime fatigue;

  • histamine intolerant.

This describes me very well prior to diagnosis.

From this, we can see that if chronic stress causes a reduction in COMT activity, then there is a nasty feedback cycle, as this makes us even less resilient to stress.

The sensitivity to stress is caused by the slow removal of Dopamine and Adrenaline, such that these build up, especially as the Dopamine is readily converted to Adrenaline due to the stress, and the Adrenaline is then slow to be removed. So Slow types tend to stay in stress longer once triggered.

As we have covered here many times before, while the high levels of Dopamine due to slower COMT removal, may be good under calm, relaxed situations, it also means that there is more available to be converted into Adrenaline under stress. Indeed, whenever Dopamine is slow to be removed by other mechanisms, it doesn’t mean we have a lot of it when we are chronically stressed, but that we will be constantly converting it to high levels of Adrenaline,

Slow COMT types have better memory and cognitive functions, however. Fast types, corresponding to higher COMT levels or activity have opposite features to Slow types, i.e. are more resilient to stress at the price of somewhat lower cognitive function. In this case, there is less Dopamine in the calm, relaxed states, but also less to convert into Adrenaline under stress, and the Adrenaline is then also quickly removed, so fast types tend not to stay stressed for so long.

Another feature of the Slow COMT type is rebound effects with supplements, where for the first day or so, a supplement makes you feel much better, but thereafter makes you feel much worse. In particular, it makes you angry, and very irritable. I have experienced this many times myself, especially whenever I’ve tried B12, methylfolate, or vitamin B1.

Suggestions for folks of the Slow type include the following

  1. A low protein diet (especially low in tyrosine and phenylalanine, as these are the precursors of Dopamine, and hence also of Adrenaline), eating regularly and maintaining blood sugar levels, as hunger can also result in the production of Adrenaline. This describes well what I have independently found suits me best, through years of trial and error.

  2. Limit strenuous exercise, as this can generate Adrenaline too. However, vigorous exercise can also burn off Adrenaline, by helping to complete fight or flight stress response cycles. Personally, I have found too vigorous exercise doesn’t suit me.

  3. Take B vitamins which help COMT to work. However, take note of the potential rebound problems covered above.

  4. Engage in stress reduction and management techniques. This allows Dopamine levels to build without converting to Adrenaline, under which circumstances Slow COMT becomes be a positive. Stress reduction has been by far the most important intervention in my own recovery.

COMT and L-DOPA

Many folks with Parkinson’s and other chronic stress related issues have similar profiles to those with a Slow COMT genetic type, as is the case for myself as explored above, albeit the disruption in COMT activity is due to being stuck in a freeze stress response, rather than genetic per se.

Folks with PD are usually supposed to have low Dopamine, so at first glance they would be more like the Fast COMT types, which removes Dopamine more quickly. So we can ask why would the Slow COMT features be more relevant?

Although low COMT activity at first glance would mean we have more Dopamine which would stay around for longer, there are still other pathways for Dopamine breakdown, including not only the MAO pathway, but also via conversion into Adrenaline. The important feature of people with PD is that they are chronically stressed, and hence tend to be constantly converting their Dopamine supplies into Adrenaline. So the lower COMT activity just means more Dopamine available for conversion into Adrenaline, and the longer we then stay stressed due to the slower removal of Adrenaline.

However, COMT inhibitors are a class of pharmaceuticals used for PD, which limit the amount of COMT activity even further. Given the above, why would this be helpful, as it would just exacerbate the Slow COMT profile?

The answer is that the COMT inhibitors are always given alongside L-Dopa drugs, as this makes the L-Dopa work better and extend the “on” times. As mentioned above COMT also breaks down L-Dopa, into something called 3-O-Methyldopa [3-OMD], meaning there is then less L-Dopa available for turning into Dopamine.

If one is reliant on external L-Dopa supplementation for generating Dopamine in the first place, then inhibiting COMT activity also means the L-Dopa lasts longer and is more available. Hence, in some cases, the inhibition of L-Dopa breakdown by COMT may outweigh the exacerbation of the other issues associated with low COMT activity.

In fact, there may be additional benefits of reducing the conversion of L-Dopa in 3-OMD via COMT activity, as 3-OMD itself can cause:

  • higher levels of dyskinesia;

  • inhibition of uptake of tyrosine;

  • competition with L-Dopa for transport across the blood–brain barrier, i.e. making it harder for L-Dopa to get to the brain;

  • inhibition of dopamine release.

In Brain Science, Diet & Supplements, Therapies Tags COMT, Dopamine, Neurotransmitters
← DAT Scans and Parkinson's DiseaseStuck on Pause with Parkinson's Disease →

ABOUT

Out-Thinking Parkinson's
Out-Thinking Parkinson's Research

 Join my Facebook Group

Follow me on substack:

BLOG

  • Re-thinking Movement
  • Digest
  • People
  • Mental Health
  • Diet & Supplements
  • Therapies
  • Toys
  • Exercise
  • Video
  • Assistive Technology
  • Music
  • Biography
  • Brain Science
  • Books
Parkinson's Disease Carousel: Original Articles and Ideas
Jun 6, 2025
Waking Up the Senses and Parkinson's Disease
Jun 6, 2025
Jun 6, 2025
Feb 19, 2025
The Nervous System and Parkinson's Disease
Feb 19, 2025
Feb 19, 2025
Sep 19, 2024
Hope and Parkinson's Disease
Sep 19, 2024
Sep 19, 2024
Aug 3, 2024
DAT Scans and Parkinson's Disease
Aug 3, 2024
Aug 3, 2024
Jun 23, 2024
Dopamine Breakdown and Parkinson's Disease: Part 2
Jun 23, 2024
Jun 23, 2024
May 3, 2024
Stuck on Pause with Parkinson's Disease
May 3, 2024
May 3, 2024
Apr 10, 2024
Dopamine Breakdown and Parkinson's Disease: Part 1
Apr 10, 2024
Apr 10, 2024
Jan 2, 2024
Fright and Parkinson's Disease
Jan 2, 2024
Jan 2, 2024
Sep 16, 2023
Acetylcholine, Dopamine and Parkinson's Disease
Sep 16, 2023
Sep 16, 2023
Jul 24, 2023
Sleep and Parkinson's Disease, Part 2
Jul 24, 2023
Jul 24, 2023
Jun 4, 2023
Emotional Armouring and Parkinson's Disease
Jun 4, 2023
Jun 4, 2023
Apr 2, 2023
Histamine, Allergies and Parkinson's Disease
Apr 2, 2023
Apr 2, 2023
Feb 8, 2023
Fascia Decompression and Parkinson's Disease
Feb 8, 2023
Feb 8, 2023
Dec 30, 2022
Lack of Oxygen to the Brain in Parkinson's Disease
Dec 30, 2022
Dec 30, 2022
Dec 13, 2022
Constipation and Parkinson's Disease
Dec 13, 2022
Dec 13, 2022
Oct 19, 2022
The Endocannabinoid System and Parkinson's Disease
Oct 19, 2022
Oct 19, 2022
Aug 21, 2022
Tremors and Parkinson's Disease
Aug 21, 2022
Aug 21, 2022
Jun 29, 2022
The Neck and Parkinson's Disease, Part 2
Jun 29, 2022
Jun 29, 2022
May 17, 2022
Reducing Stress and Parkinson's Disease
May 17, 2022
May 17, 2022
Apr 7, 2022
Thiamine and Parkinson's Disease
Apr 7, 2022
Apr 7, 2022
Mar 6, 2022
Stress, Situations, Symptoms and Parkinson's Disease
Mar 6, 2022
Mar 6, 2022
Feb 18, 2022
Early Retirement and Parkinson's Disease
Feb 18, 2022
Feb 18, 2022
Feb 3, 2022
Survival Instincts and Parkinson's Disease
Feb 3, 2022
Feb 3, 2022
Dec 13, 2021
Feeling Trapped and Parkinson's Disease
Dec 13, 2021
Dec 13, 2021
Nov 4, 2021
Motivation, Pleasure, Pain and Parkinson's Disease
Nov 4, 2021
Nov 4, 2021
Oct 2, 2021
Dopamine Cell Receptors and Parkinson's Disease
Oct 2, 2021
Oct 2, 2021
Aug 15, 2021
Dopamine and Parkinson's Disease
Aug 15, 2021
Aug 15, 2021
Jul 26, 2021
Visual Cues and Parkinson's Disease
Jul 26, 2021
Jul 26, 2021
Jul 10, 2021
The Eyes and Parkinson's Disease
Jul 10, 2021
Jul 10, 2021
Jun 25, 2021
Eye Exercises and Parkinson's Disease
Jun 25, 2021
Jun 25, 2021

insights

  • Person with PD
  • Caregiver
  • Reader
  • Author
  • Therapist
Testimonials Carousel: What People Say
Mar 13, 2025
Coloring with Parkinson's
Mar 13, 2025
Mar 13, 2025
Nov 28, 2024
Very Encouraging and Refreshing
Nov 28, 2024
Nov 28, 2024
Apr 19, 2024
Stuck on Pause
Apr 19, 2024
Apr 19, 2024
Aug 12, 2023
Photobiomodulation or Red Light Therapy
Aug 12, 2023
Aug 12, 2023
Jul 7, 2022
Tremors Reduced
Jul 7, 2022
Jul 7, 2022
Mar 29, 2022
Accessible Knowledge
Mar 29, 2022
Mar 29, 2022
Oct 19, 2021
Staying Positive
Oct 19, 2021
Oct 19, 2021
Jul 28, 2021
Suggestions for Exploration
Jul 28, 2021
Jul 28, 2021
Jun 20, 2021
Educative Posts
Jun 20, 2021
Jun 20, 2021
Mar 24, 2021
Parallels with Trauma
Mar 24, 2021
Mar 24, 2021
Feb 4, 2021
Correcting Dysfunctional Sleep
Feb 4, 2021
Feb 4, 2021
Oct 27, 2020
REM Sleep Behaviour Disorder
Oct 27, 2020
Oct 27, 2020
Aug 11, 2020
Yoga Therapy
Aug 11, 2020
Aug 11, 2020
Nov 27, 2019
Strategies of Recovery
Nov 27, 2019
Nov 27, 2019
Sep 3, 2019
Applications of Polyvagal Theory
Sep 3, 2019
Sep 3, 2019
May 24, 2019
Hope and Inspiration
May 24, 2019
May 24, 2019
Feb 7, 2019
Headed in the Right Direction
Feb 7, 2019
Feb 7, 2019
Sep 10, 2018
Husband Diagnosed
Sep 10, 2018
Sep 10, 2018
Sep 10, 2018
Making Changes
Sep 10, 2018
Sep 10, 2018
Jun 21, 2018
Craniosacral Therapy
Jun 21, 2018
Jun 21, 2018
May 27, 2018
Music is Medicine
May 27, 2018
May 27, 2018
Apr 26, 2018
Social Isolation
Apr 26, 2018
Apr 26, 2018
Mar 31, 2018
From Malta
Mar 31, 2018
Mar 31, 2018
Mar 6, 2018
Impactful Discoveries
Mar 6, 2018
Mar 6, 2018
Mar 6, 2018
Co-Regulation
Mar 6, 2018
Mar 6, 2018
Feb 6, 2018
Outstanding Information
Feb 6, 2018
Feb 6, 2018
Jan 21, 2018
Slowing Down Progression
Jan 21, 2018
Jan 21, 2018
Oct 25, 2017
Exploring All the Potential Causes
Oct 25, 2017
Oct 25, 2017
Sep 10, 2017
Can-Do Attitude
Sep 10, 2017
Sep 10, 2017
Aug 28, 2017
Connecting the Dots
Aug 28, 2017
Aug 28, 2017

©2017-2024 Gary Sharpe, ©2016 Gary Sharpe and Deb Helfrich

Contact Us

Medical Disclaimer

Website Terms & Conditions